FDA Panel Votes Against Acadia (ACAD) sNDA for Nuplazid

Published on 21 Jun 2022 on MSN News

Acadia Pharmaceuticals Inc. ACAD announced that the FDA’s Psychopharmacologic Drugs Advisory...

Read the rest of the article

Start tracking your investments with Statfolio

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript May 8, 2024 ACADIA Pha...

Insider Monkey via Yahoo Finance 9 May 2024

Acadia Pharmaceuticals Inc. ACAD reported first-quarter 2024 earnings of 10 cents per share, beat...

Zacks via Yahoo Finance 8 May 2024

The earnings season for the drug/biotech sector is now in its final lap, with two S&P 500 compani...

Zacks via Yahoo Finance 6 May 2024

On May 2, 2024, Stephen Davis, the CEO of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), sold 11,427 s...

GuruFocus.com via Yahoo Finance 4 May 2024

Stephen Davis, CEO of Acadia Pharmaceuticals Inc. (NASDAQ:ACAD), recently sold 11,427 shares of t...

Investing.com 3 May 2024

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), a biopharmaceutical company focused on the development ...

GuruFocus.com via Yahoo Finance 10 Apr 2024

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) has reported a recent transaction involving its executi...

Investing.com 9 Apr 2024

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) has reported a recent transaction involving James Kihar...

Investing.com 9 Apr 2024

Stephen Davis, the CEO of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), has sold 17,714 shares of the...

GuruFocus.com via Yahoo Finance 27 Mar 2024

Monday, Acadia Pharmaceuticals Inc ACAD released top-line results from the Phase 3 ADVANCE-2 tria...

Benzinga 12 Mar 2024